Rebecca A. Wright - Concepedia

Author

Rebecca A. Wright

Also Known As

R Wright, R. A. WRIGHT, R. A. Wright, R. Alan Wright, R. Wright, R.A WRIGHT, R.A Wright, R.A. Wright, Rebecca A Wright, Rebecca A. Wright

113

Publications

6.4K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Salk Institute for Biological Studies University of California San Diego Yale University Icahn School of Medicine at Mount Sinai

About

Rebecca A. Wright is an author at Eli Lilly (United States) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	41	3.5K
2	Natural Sciences	13	14	1.2K
3	Social Sciences	11	11	1K
4	Health Sciences	3	3	220
5	Engineering	1	1	33

Rebecca A. Wright

Publications

Citations

H-Index

Page 1

	Year	Citations
Altered proliferation and networks in neural cells derived from idiopathic autistic individuals Maria C. Marchetto, Haim Belinson, Yuan Tian, Molecular Psychiatry Neural CellsDevelopmental BiologySyndromic AutismIdiopathic Autistic IndividualsNeurodevelopment	2016	482
Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties James A. Monn, Matthew J. Valli, Steven M. Massey, Journal of Medicinal Chemistry Pharmacological CharacterizationActive Group 2Psychotropic MedicationPharmacotherapyChemical Biology	1997	392
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors Anne Kingston, Paul L. Ornstein, Rebecca A. Wright, Neuropharmacology Functional SelectivityMedicineDrug DiscoveryMechanism Of ActionReceptor (Biochemistry)	1998	364
Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs Amy L. Firth, Tushar Menon, Gregory S. Parker, Cell Reports	2015	318
Synthesis, Pharmacological Characterization, and Molecular Modeling of Heterobicyclic Amino Acids Related to (+)-2-Aminobicyclo[3.1.0]hexane- 2,6-dicarboxylic Acid (LY354740): Identification of Two New Potent, Selective, and Systemically Active Agonists for Group II Metabotropic Glutamate Receptors James A. Monn, Matthew J. Valli, Steven M. Massey, Journal of Medicinal Chemistry Active AgonistsMglu ReceptorsPharmacotherapyChemical BiologyPharmaceutical Chemistry	1999	286
Physiological Antagonism between 5-Hydroxytryptamine2A and Group II Metabotropic Glutamate Receptors in Prefrontal Cortex Gerard J. Marek, Rebecca A. Wright, Darryle D. Schoepp, Journal of Pharmacology and Experimental Therapeutics	2000	279
Modeling Hippocampal Neurogenesis Using Human Pluripotent Stem Cells Diana Yu, Francesco Paolo Di Giorgio, Jun Yao, Stem Cell Reports	2014	260
Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells Amy L. Firth, Carl Dargitz, Susan J. Qualls, Proceedings of the National Academy of Sciences Inflammatory Lung DiseaseMulticiliated CellsAdult Stem CellCellular PhysiologyRegenerative Medicine	2014	243
LY354740 is a Potent and Highly Selective Group II Metabotropic Glutamate Receptor Agonist in Cells Expressing Human Glutamate Receptors Darryle D. Schoepp, Bryan G. Johnson, Rebecca A. Wright, Neuropharmacology Functional SelectivityMedicineNeurotransmitterNeuropharmacologyNeuroscience	1997	225
SOX2 primes the epigenetic landscape in neural precursors enabling proper gene activation during hippocampal neurogenesis Alejandro Amador‐Arjona, Flavio Cimadamore, Chun‐Teng Huang, Proceedings of the National Academy of Sciences	2015	174

Page 1